Company / SG&A per Share
HealthEquity SG&A per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.20
FY2026
5-year range
$0.78 / $1.56
FY2022-FY2026
Trend
-14.0%
vs FY2025
Sector context
#129 of 156
Health Care
What the data says
HealthEquity's sg&a per share of $1.20 is lower than 83% of companies in the Health Care sector (FY2026). SG&A per Share has fluctuated over the past 10 years, ranging from $0.44 in FY2017 to $1.56 in FY2024.
Based on SEC 10-K filings.
1.20 in FY2026 with a 5-year CAGR of +20.8%.
Improved from $1.56 to $1.20 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- +20.8%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 156This company $1.20 Sector average $11421.53
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2026, sg&a per share decreased 14.0% year-over-year.
- Ranks #129 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $1.20 | -14.0% |
| FY2025 | $1.39 | -10.8% |
| FY2024 | $1.56 | +26.1% |
| FY2023 | $1.24 | +57.7% |
| FY2022 | $0.78 | +68.8% |
| FY2021 | $0.47 | -65.6% |
| FY2020 | $1.35 | +35.9% |
| FY2019 | $1.00 | +79.4% |
| FY2018 | $0.55 | +27.6% |
| FY2017 | $0.44 | +18.3% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026